3M Canada Release: Health Canada Approves New Cream Treatment For Skin Cancer
10/19/2005 5:12:01 PM
TORONTO, Jan. 6 /CNW/ - Health Canada has approved ALDARA(TM) (imiquimod) Cream, 5%, a topical prescription medication for the treatment of superficial basal cell carcinoma (sBCC) - a form of non-melanoma skin cancer. ALDARA is the first new treatment for this type of cancer to be approved in Canada in close to 30 years and is the first in a new class of medications called immune response modifiers. The medication works by triggering the body's immune system to find and kill mutated cells on the outer layer of the skin.
comments powered by